Fujian Wanchen Biotechnology Group Co.,Ltd. (SHE:300972)

SHE:300972 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	43,658	31,885	9,234	549.11	434.7	449.89
Other Revenue	337.75	443.67	60.17	0.15	-	0.1
Revenue	43,996	32,329	9,294	549.26	434.7	449.98
Revenue Growth (YoY)	144.53%	247.86%	1592.03%	26.35%	-3.40%	-0.21%
Cost of Revenue	39,100	28,869	8,440	462.11	391.7	325.24
Gross Profit	4,896	3,460	854.2	87.15	43.01	124.74
Selling, General & Admin	2,887	2,405	875.54	51.39	25.21	22.04
Research & Development	4.5	4.04	3.31	1.95	1.99	0.43
Other Operating Expenses	74.95	63.42	20.97	3.29	3.09	2.85
Operating Expenses	2,972	2,474	900.52	57.41	30.32	25.33
Operating Income	1,923	986.02	-46.32	29.74	12.68	99.41
Interest Expense	-57.2	-50.85	-28.75	-4.2	-5.18	-7.55
Interest & Investment Income	17.98	14.11	1.68	3.18	3.01	0.33
Currency Exchange Gain (Loss)	-0	-0	-0	-	-0	-0
Other Non Operating Income (Expenses)	5.6	-5.88	-7.22	-0.2	-0.07	0.03
EBT Excluding Unusual Items	1,890	943.4	-80.6	28.52	10.44	92.21
Gain (Loss) on Sale of Investments	-	-	-	0.2	0.03	-
Gain (Loss) on Sale of Assets	-2.14	-8.3	-3.26	-1.66	-0.49	-0.1
Asset Writedown	-13.86	-11.05	-4.04	-0.31	-0.1	-0.05
Other Unusual Items	99.68	108.38	3.19	14.83	19.18	4.07
Pretax Income	1,973	1,032	-84.72	41.58	29.06	96.13
Income Tax Expense	643.63	429.18	61.3	0.04	5.61	-
Earnings From Continuing Operations	1,330	603.26	-146.02	41.54	23.45	96.13
Minority Interest in Earnings	-565.63	-309.74	63.1	6.2	-	-
Net Income	764.15	293.52	-82.93	47.74	23.45	96.13
Net Income to Common	764.15	293.52	-82.93	47.74	23.45	96.13
Net Income Growth	-	-	-	103.57%	-75.61%	4.28%
Shares Outstanding (Basic)	179	171	154	153	141	114
Shares Outstanding (Diluted)	197	187	154	155	141	114
Shares Change (YoY)	23.65%	21.78%	-0.92%	10.29%	22.92%	-0.69%
EPS (Basic)	4.26	1.71	-0.54	0.31	0.17	0.84
EPS (Diluted)	3.89	1.57	-0.54	0.31	0.17	0.84
EPS Growth	-	-	-	84.58%	-80.16%	5.00%
Free Cash Flow	1,489	731.69	804.17	-245.96	57.25	100.14
Free Cash Flow Per Share	7.58	3.91	5.23	-1.58	0.41	0.88
Dividend Per Share	0.600	0.600	-	-	0.220	-
Gross Margin	11.13%	10.70%	9.19%	15.87%	9.89%	27.72%
Operating Margin	4.37%	3.05%	-0.50%	5.42%	2.92%	22.09%
Profit Margin	1.74%	0.91%	-0.89%	8.69%	5.39%	21.36%
Free Cash Flow Margin	3.38%	2.26%	8.65%	-44.78%	13.17%	22.25%
EBITDA	2,029	1,090	42.08	89.94	73.92	159.01
EBITDA Margin	4.61%	3.37%	0.45%	16.38%	17.00%	35.34%
D&A For EBITDA	105.29	104.02	88.4	60.2	61.24	59.61
EBIT	1,923	986.02	-46.32	29.74	12.68	99.41
EBIT Margin	4.37%	3.05%	-0.50%	5.42%	2.92%	22.09%
Effective Tax Rate	32.62%	41.57%	-	0.10%	19.31%	-
Revenue as Reported	43,996	32,329	9,294	549.26	434.7	449.98
Advertising Expenses	-	513.2	50.2	0.42	0.07	0.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.